Get the Stockscreener App
87.51
2.41%
2.06
Lemaitre Vascular Inc stock is traded at $87.51, with a volume of 218.28K.
It is up +2.41% in the last 24 hours and down -8.24% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
See More
Previous Close:
$85.45
Open:
$85.46
24h Volume:
218.28K
Relative Volume:
1.30
Market Cap:
$1.98B
Revenue:
$213.03M
Net Income/Loss:
$41.32M
P/E Ratio:
47.82
EPS:
1.83
Net Cash Flow:
$33.49M
1W Performance:
-2.63%
1M Performance:
-8.24%
6M Performance:
+4.30%
1Y Performance:
-5.79%
1-Day Range:
$84.44
$88.08
1-Week Range:
$83.88
$90.02
52-Week Range:
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
87.51 | 1.93B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
447.23 | 157.45B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
187.17 | 52.74B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
273.73 | 39.69B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
74.51 | 36.64B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
262.33 | 18.72B | 2.96B | 487.70M | 344.00M | 6.68 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Feb-28-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Feb-28-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-13-25 | Initiated | Wells Fargo | Equal Weight |
| Oct-15-24 | Initiated | Cantor Fitzgerald | Neutral |
| Aug-02-24 | Resumed | Lake Street | Buy |
| May-31-24 | Resumed | ROTH MKM | Buy |
| Apr-26-24 | Upgrade | Stifel | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-06-23 | Initiated | Oppenheimer | Outperform |
| Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
| May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-16-21 | Initiated | Jefferies | Buy |
| Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
| Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jul-25-19 | Reiterated | Barrington Research | Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
| Jun-08-18 | Resumed | ROTH Capital | Buy |
| Apr-26-18 | Downgrade | Stifel | Buy → Hold |
| Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-21-17 | Initiated | First Analysis Sec | Overweight |
| Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
| Jul-28-16 | Reiterated | Barrington Research | Outperform |
| Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
How LeMaitre Vascular Inc. (LHU) stock reacts to Fed tighteningMarket Volume Report & Capital Efficient Trading Techniques - newser.com
What drives LeMaitre Vascular Inc stock priceVWAP Trading Strategies & Build Diversified Portfolios With Ease - earlytimes.in
What analysts say about LeMaitre Vascular Inc stockMarket Sentiment Report & Superior Trading Ideas - earlytimes.in
What MACD and RSI say about LeMaitre Vascular Inc.July 2025 Market Mood & Precise Entry and Exit Recommendations - newser.com
Multi asset correlation models including LeMaitre Vascular Inc.July 2025 Levels & Low Drawdown Momentum Ideas - newser.com
Smart tools for monitoring LeMaitre Vascular Inc.’s price action2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - newser.com
LeMaitre Vascular Inc. stock chart pattern explainedTrade Analysis Report & Long-Term Safe Investment Plans - newser.com
Using R and stats models for LeMaitre Vascular Inc. forecasting2025 Year in Review & Growth Oriented Trade Recommendations - newser.com
Will a bounce in LeMaitre Vascular Inc. offer an exit2025 AllTime Highs & Detailed Earnings Play Alerts - newser.com
Analyzing LeMaitre Vascular Inc. with risk reward ratio chartsJuly 2025 Gainers & Free Reliable Trade Execution Plans - newser.com
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - simplywall.st
Congress Asset Management Co. Has $55.97 Million Position in LeMaitre Vascular, Inc. $LMAT - Defense World
Oversold Conditions For LeMaitre Vascular (LMAT) - Nasdaq
LeMaitre Vascular (NASDAQ:LMAT) Has A Rock Solid Balance Sheet - 富途牛牛
LeMaitre Vascular (NASDAQ:LMAT) Receives “Outperform” Rating from Barrington Research - Defense World
LeMaitre to Participate at Upcoming Investor Conferences in September - 富途牛牛
LeMaitre Vascular (NASDAQ:LMAT) Given Outperform Rating at Barrington Research - MarketBeat
Analyst Michael Petusky Maintains Outperform Rating on LMAT | LM - GuruFocus
LeMaitre Vascular, Inc. $LMAT Stake Raised by Annex Advisory Services LLC - MarketBeat
visual analytics tools that track lemaitre vascular inc. performanceJuly 2025 Review & Expert Approved Momentum Ideas - newser.com
Voya Investment Management LLC Sells 23,752 Shares of LeMaitre Vascular, Inc. $LMAT - Defense World
LeMaitre Vascular Experiences Evaluation Revision Amidst Mixed Market Signals and Strong Long-Term Performance - Markets Mojo
15,618 Shares in LeMaitre Vascular, Inc. $LMAT Bought by Caitlin John LLC - MarketBeat
Voya Investment Management LLC Has $1.79 Million Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular, Inc. $LMAT Shares Acquired by Wesbanco Bank Inc. - MarketBeat
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.91%
1.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):